info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143841 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O4 |
| Mol.Wt. | 473.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143842 |
| CAS No | NA |
| Mol.F. | C26H32ClN7O5 |
| Mol.Wt. | 558.04 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143843 |
| CAS No | NA |
| Mol.F. | C26H32ClN7O5 |
| Mol.Wt. | 558.04 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143844 |
| CAS No | NA |
| Mol.F. | C20H22ClN7O2 |
| Mol.Wt. | 427.89 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143845 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O2 |
| Mol.Wt. | 441.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143846 |
| CAS No | NA |
| Mol.F. | C22H24ClN7O2 |
| Mol.Wt. | 453.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143847 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O2 |
| Mol.Wt. | 441.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143848 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O2 |
| Mol.Wt. | 441.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143849 |
| CAS No | NA |
| Mol.F. | C20H23ClN8O2 |
| Mol.Wt. | 442.91 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143850 |
| CAS No | NA |
| Mol.F. | C22H26ClN7O3 |
| Mol.Wt. | 471.95 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143851 |
| CAS No | NA |
| Mol.F. | C22H26ClN7O3 |
| Mol.Wt. | 471.95 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143852 |
| CAS No | NA |
| Mol.F. | C20H22ClN7O3 |
| Mol.Wt. | 443.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143853 |
| CAS No | NA |
| Mol.F. | C23H29ClN8O2 |
| Mol.Wt. | g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143854 |
| CAS No | NA |
| Mol.F. | C14H16N4O3 |
| Mol.Wt. | 288.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143855 |
| CAS No | NA |
| Mol.F. | C11H19N3O5 |
| Mol.Wt. | 273.29 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143856 |
| CAS No | NA |
| Mol.F. | C18H25N3O5 |
| Mol.Wt. | 363.41g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
